iRhythm Technologies, Inc.
iRhythm Technologies is a cardiac monitoring device maker with minimal direct government dependence but significant Medicare reimbursement exposure and light political engagement.
BusinessWhat IRTC does
iRhythm develops and commercializes digital health solutions for cardiac arrhythmia detection, primarily wearable monitoring devices and cloud-based analytics. Revenue is driven by device sales and recurring monitoring services, with substantial reimbursement from Medicare and private insurers.
Lifetime Government AwardsIRTC federal contracts by year
Smart Money · 13F HoldingsHedge funds holding IRTC
Politicians Trading IRTCMembers of Congress with recent IRTC positions
Congressional TradesWho in Congress is trading IRTC
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills to WatchLegislation flagged by our analysis
Political ProfileWhere IRTC sits in Washington
iRhythm has minimal lobbying footprint and no identifiable congressional champions/critics. Stock movement is primarily driven by clinical trial results, reimbursement decisions, and competitive dynamics rather than legislative events.
Regulatory ExposureThreats & opportunities
Regulatory threats
- CMS reimbursement rate cuts
- FDA reclassification to higher regulatory class
- Prior authorization expansion
Regulatory opportunities
- Remote monitoring coverage expansion
- Telehealth reimbursement parity
- Streamlined FDA approval pathways
Live signals + predictions for IRTC — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades IRTC
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord